FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of QSV Biologics

QSV Biologics Ltd. announces the appointment of Dr. William Cochrane O.C., M.D., as Chairman of its Board.

20-Jan-2009 - QSV Biologics Ltd announced the appointment of Dr. William Cochrane O.C., M.D., as Chairman of its Board of Directors. Dr. Cochrane's career accomplishments encompass the fields of medicine, biomedical research, education, government and business, spanning Canada, the U.K. and U.S.A. Following ...

Bio-Medical Research biotechnology education +4

QSV Biologics, Ltd. and Critical Biologics Corp. Sign 2nd Contract for cGMP Manufacture of Plasma Gelsolin

18-Aug-2008 - QSV Biologics, Ltd (QSV) and Critical Biologics Corp. (CBC) announced the signing of a second, repeat business, contract for the cGMP manufacturing of recombinant human plasma gelsolin (Solinex(TM)) being targeted for various critical care applications and end-stage renal disease patients on ...

clinical trials dialysis diseases +4

Phase III Clinical & Commercial cGMP Manufacturing Agreement Signed by Celtic Pharma and QSV Biologics, Ltd., for TransMID

12-Jan-2007 - QSV Biologics, Ltd (QSV) and Celtic Pharmaceutical Holdings L.P. (Celtic Pharma) announced the signing of a cGMP manufacturing agreement for TransMID(TM). QSV will be responsible for cGMP manufacture of further phase III clinical trial material and longer term commercial manufacture in their ...

brain tumors clinical trials glioblastoma multiforme

QSV Biologics contract cGMP manufacturer moves ahead.

20-Jun-2005 - QSV Biologics, a North American based contract biopharmaceutical manufacturer, continues to expand its operations and capabilities. Since January 2005 QSV has validated an additional two new cGMP manufacturing suites and is looking to construct another cGMP suite within its current facility. The ...